CA2386278A1 - Dip coating compositions containing starch or dextrin - Google Patents
Dip coating compositions containing starch or dextrinInfo
- Publication number
- CA2386278A1 CA2386278A1 CA002386278A CA2386278A CA2386278A1 CA 2386278 A1 CA2386278 A1 CA 2386278A1 CA 002386278 A CA002386278 A CA 002386278A CA 2386278 A CA2386278 A CA 2386278A CA 2386278 A1 CA2386278 A1 CA 2386278A1
- Authority
- CA
- Canada
- Prior art keywords
- percent
- composition
- comprised
- mixtures
- subcoating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
Abstract
Water soluble, gelatin-free dip coatings for tablets and capsules comprising sucrose, glycerin and pre-gelatinized starch and/or tapioca dextrin or comprising hydroxypropyl starch, thickener, and plasticizer.
Claims (35)
1. A film forming composition comprised of:
a) a film forrnes selected from the group consisting of a waxy maize starch, tapioca dextrin, derivative of a waxy maize starch, derivative of tapioca dextrin, and mixtures thereof;
b) a thickener selected from the group consisting of sucrose, dextrose, fructose, and mixtures thereof; and c) a plasticizes, wherein the composition possesses a surface gloss of at least 150 when applied via dip coating to a substrate.
a) a film forrnes selected from the group consisting of a waxy maize starch, tapioca dextrin, derivative of a waxy maize starch, derivative of tapioca dextrin, and mixtures thereof;
b) a thickener selected from the group consisting of sucrose, dextrose, fructose, and mixtures thereof; and c) a plasticizes, wherein the composition possesses a surface gloss of at least 150 when applied via dip coating to a substrate.
2. A film forming composition comprised of:
a) a hydroxypropyl starch film former;
b) a thickener selected from the group consisting of kappa carrageenan, iota carrageenan, maltodextrin, gellan gum, agar, gelling starch, and derivatives and mixtures thereof;
and c) a plasticizes, wherein the composition possesses a surface gloss of at least 150 when applied via dip coating to a substrate.
a) a hydroxypropyl starch film former;
b) a thickener selected from the group consisting of kappa carrageenan, iota carrageenan, maltodextrin, gellan gum, agar, gelling starch, and derivatives and mixtures thereof;
and c) a plasticizes, wherein the composition possesses a surface gloss of at least 150 when applied via dip coating to a substrate.
3. The composition of claim 1, wherein the plasticizers are selected from the group consisting of polyethylene glycol, glycerin, sorbitol, triethyl citrate, tribuyl citrate, dibutyl sebecate, vegetable oils, surfactants, propylene glycol, mono acetate of glycerol, diacetate of glycerol, triacetate of glycerol, natural gums, and mixtures thereof.
4. The composition of claim 2 wherein the plasticizes is selected from the group consisting of glycerin, propylene glycol, polyethylene glycol, sugar alcohols and derivatives and mixtures thereof.
5. The composition of claim 1 wherein the plasticizes is glycerin.
6. The composition of claim 1 wherein the plasticizes is glycerin and the thickener is sucrose.
7. The composition of claim 1, wherein the composition is comprised of, based upon the total dry weight of the composition, a) from about 40 percent to about 60 percent of a film former selected from the group consisting of a waxy maize starch, tapioca dextrin, derivative of a waxy maize starch, derivative of tapioca dextrin, and mixtures thereof;
b) from abet 10 percent to about 20 percent of sucrose; and c) from about 20 percent to about 25 percent of glycerin.
b) from abet 10 percent to about 20 percent of sucrose; and c) from about 20 percent to about 25 percent of glycerin.
8. The composition of claim 7, wherein the composition is comprised of, based upon the total dry weight of the composition, a) from about 50 percent to about 55 percent of a film former selected from the group consisting of a waxy maize starch, tapioca dextrin, derivative of a waxy maize starch, derivative of tapioca dextrin, and mixtures thereof;
b) from about 5 percent to about 25 percent of sucrose; and c) from about 15 percent to about 30 percent of glycerin.
b) from about 5 percent to about 25 percent of sucrose; and c) from about 15 percent to about 30 percent of glycerin.
9. The composition of claim 7 further comprising a weight enhancer selected from the group consisting of simethicone, polysorbate 80, and mixtures thereof.
10. The composition of claim 7 further comprising, based upon the total weight of the composition, up to about 14 percent of a coloring agent.
11. A dosage form for delivering active agents, said form comprising an outer coating, said outer coating comprising the composition of claim 6.
12. A pharmaceutical dosage form comprising an outer coating of the composition of claim 7.
13. A pharmaceutical dosage form comprising a core, a subcoating substantially covering said core, and an outer coating substantially covering said subcoating, wherein the outer coating is comprised of the composition of claim 7.
14. The dosage form of claim 13 wherein the subcoating is selected from the group consisting of hydroxypropylmethyl cellulose, castor oil, maltodextrins, polyethylene glycol, polysorbate 80, and mixtures thereof.
15. The dosage form of claim 13 wherein the subcoating is comprised of, based upon the total dry weight of the subcoating, a) from about 2 percent to about 8 percent hydroxypropylmethylcellulose; and b) from about 0.1 percent to about 1 percent castor oil.
16. The dosage form of claim 13 wherein the subcoating is comprised of, based upon the total dry weight of the subcoating, a) from about 25 percent to about 40 percent hydroxypropylmethylcellulose;
b) from about 50 percent to about 20 percent maltodextrin; and c) from about 5 percent to about 10 percent PEG 400.
b) from about 50 percent to about 20 percent maltodextrin; and c) from about 5 percent to about 10 percent PEG 400.
17. The dosage form of claim 13 wherein the subcoating is comprised of, based upon the total dry weight of the subcoating, a) from about 20 percent ko about 50 percent hydroxyethylcellulose;
b) from about 45 percent to about 75 percent maltodextrin; and c) from about 1 percent to about 10 percent PEG 400.
b) from about 45 percent to about 75 percent maltodextrin; and c) from about 1 percent to about 10 percent PEG 400.
18. A tablet dip coated with the film forming composition according to claim 7.
19. The dosage form of claim 13, comprising an effective amount of a pharmaceutical active ingredient, wherein said dosage form meets USP dissolution requirements for immediate release forms of said pharmaceutical active ingredient.
20. An aqueous dispersion comprised of the composition of claim 7.
21. The aqueous dispersions of claim 20 comprising, based upon the total weight of the dispersion:
a) from about 5 percent to about 15 percent of sucrose;
b) from about 10 percent to about 15 percent of glycerin; and c) from about 20 percent to about 35 percent of a film former selected from the group consisting of a waxy maize starch, tapioca dextrin, derivative of a waxy maize starch, derivative of tapioca dextrin, and mixtures thereof.
a) from about 5 percent to about 15 percent of sucrose;
b) from about 10 percent to about 15 percent of glycerin; and c) from about 20 percent to about 35 percent of a film former selected from the group consisting of a waxy maize starch, tapioca dextrin, derivative of a waxy maize starch, derivative of tapioca dextrin, and mixtures thereof.
22. A method of making coated tablets from the aqueous dispersions of claim 20 comprising dip coating tablets in the aqueous dispersion under conditions sufficient.
23. A pharmaceutical dosage form comprising a core and a coating;
said coating substantially covering said core, wherein said coating is comprised of the composition of claim 6.
said coating substantially covering said core, wherein said coating is comprised of the composition of claim 6.
24. A simulated capsule-like medicament comprising:
a. a core having a first and a seed end, b. a first coating layer having a first color provided on said first end of said core;
c. a second coating layer having a second color on said second end of said core, said first color is different than said second color;
wherein at least one of said first coating layer and second coating layer is comprised of a coating layer composition comprised of the composition of claim 6 .
a. a core having a first and a seed end, b. a first coating layer having a first color provided on said first end of said core;
c. a second coating layer having a second color on said second end of said core, said first color is different than said second color;
wherein at least one of said first coating layer and second coating layer is comprised of a coating layer composition comprised of the composition of claim 6 .
25. The medicament of claim 24 wherein at least one coating layer is comprised of, based upon the total dry weight of that coating layer, a) from about 40 percent to about 60 percent of a film former selected from waxy maize starch, tapioca dextrin, and derivatives, and mixtures thereof;
b) from about 10 percent to about 20 percent of sucrose; and c) from about 20 percent to about 25 percent of glycerin.
b) from about 10 percent to about 20 percent of sucrose; and c) from about 20 percent to about 25 percent of glycerin.
26. The medicament of claim 25 further comprising a subcoating layer substantially covering said tablet core, said subcoating layer provided between said tablet core and said first coating layer and said second coating layer.
27. The medicament of claim 26 wherein the subcoating comprises materials selected from the group consisting of cellulose ethers, plasticizers, polycarbohydrates, pigments, opacifiers, and mixtures thereof.
28. The composition of claim 2, wherein the composition is comprised of, based upon the total dry weight of the composition, a) from about 25 percent to about 80 percent of hydroxypropyl starch;
b) from about 0.1 percent to about 33 percent of a thickener selected from the group consisting of kappa carrageenan, iota carrageenan, maltodextrin, gellan gum, agar, gelling starch, and mixtures thereof; and c) from about 11 percent to about 80 percent of a plasticizer selected from the group consisting of glycerin, propylene glycol, polyethylene glycol, sugar alcohols and mixtures thereof.
b) from about 0.1 percent to about 33 percent of a thickener selected from the group consisting of kappa carrageenan, iota carrageenan, maltodextrin, gellan gum, agar, gelling starch, and mixtures thereof; and c) from about 11 percent to about 80 percent of a plasticizer selected from the group consisting of glycerin, propylene glycol, polyethylene glycol, sugar alcohols and mixtures thereof.
29. A dosage form for delivering active agents, said form comprising an outer coating, said outer coating comprising the composition of claim 4
30. A pharmaceutical dosage form comprising a core, a subcoating substantially covering said core, and an outer coating substantially covering said subcoating, wherein the outer coating is comprised of the composition of claim 4.
31. A simulated capsule-like medicament comprising:
a. a core having a first and a second end, b. a first coating layer having a first color provided on said first end of said core;
c. a second coating layer having a second color on said second end of said core, said first color is different than said second color;
wherein at least one of said first coating layer and second coating layer is comprised of a coating layer composition comprised of the composition of claim 4.
a. a core having a first and a second end, b. a first coating layer having a first color provided on said first end of said core;
c. a second coating layer having a second color on said second end of said core, said first color is different than said second color;
wherein at least one of said first coating layer and second coating layer is comprised of a coating layer composition comprised of the composition of claim 4.
32. The composition of claim 2, wherein the plasticizers are selected from the group consisting of polyethylene glycol, glycerin, sorbitol, methyl citrate, tribuyl citrate, dibutyl sebecate, vegetable oils, surfactants, propylene glycol, mono acetate of glycerol, diacetate of glycerol, triacetate of glycerol, natural gums, and mixtures thereof.
33. The composition of claim 2 wherein the plasticizer is glycerin.
34. The composition of claim 2 wherein the gelling starch is hydroxypropyl distarch phosphate.
35. The composition of claim 2 wherein the gelling starch is an acid hydrolyzed starch.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29112701P | 2001-05-15 | 2001-05-15 | |
US60/291,127 | 2001-05-15 | ||
US32572601P | 2001-09-28 | 2001-09-28 | |
US60/325,726 | 2001-09-28 | ||
US10/122,999 US20030070584A1 (en) | 2001-05-15 | 2002-04-12 | Dip coating compositions containing cellulose ethers |
US10/122,999 | 2002-04-12 | ||
US10/122,531 US20030072731A1 (en) | 2001-05-15 | 2002-04-15 | Dip coating compositions containing starch or dextrin |
US10/122,531 | 2002-04-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2386278A1 true CA2386278A1 (en) | 2002-11-15 |
CA2386278C CA2386278C (en) | 2010-08-24 |
Family
ID=27494435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2386278A Expired - Fee Related CA2386278C (en) | 2001-05-15 | 2002-05-14 | Dip coating compositions containing starch or dextrin |
Country Status (13)
Country | Link |
---|---|
US (1) | US20090092739A1 (en) |
EP (1) | EP1260218B1 (en) |
JP (1) | JP2003089659A (en) |
KR (1) | KR20020087367A (en) |
CN (1) | CN1388190A (en) |
AR (1) | AR035899A1 (en) |
AT (1) | ATE516798T1 (en) |
AU (1) | AU4061702A (en) |
BR (1) | BR0201905A (en) |
CA (1) | CA2386278C (en) |
CO (1) | CO5390071A1 (en) |
MX (1) | MXPA02004824A (en) |
NZ (1) | NZ518951A (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7879354B2 (en) * | 2004-01-13 | 2011-02-01 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
CN1333006C (en) * | 2005-04-07 | 2007-08-22 | 天津大学 | Vegetable capsule of starch composition and preparation method |
JP5021263B2 (en) * | 2006-10-02 | 2012-09-05 | 中日本カプセル 株式会社 | Film composition |
US8574624B2 (en) | 2006-11-17 | 2013-11-05 | Corn Products Development, Inc. | Highly inhibited starch fillers for films and capsules |
CN101245157B (en) * | 2007-02-17 | 2011-06-15 | 长春大成特用玉米变性淀粉开发有限公司 | Film-forming agent composition and starchiness vegetable adhesive containing the composition |
BRPI0816929A2 (en) * | 2007-09-17 | 2015-03-17 | Mcneil Ppc Inc | Dip-coated compositions containing polyvinyl alcohol and polyethylene glycol copolymer as well as a gum |
CL2008003230A1 (en) * | 2007-11-01 | 2009-11-27 | Sanofi Aventis Healthcare Pty Ltd | Tablet coating composition comprising cellulosic polymer, plasticizer, sweetener and powder flavor composition which comprises flavor associated with solid carrier; tablet coating fluid comprising said composition; pharmaceutical tablet; process of preparing said tablet. |
ES2384305T3 (en) | 2008-02-19 | 2012-07-03 | Mcneil-Ppc, Inc. | Immersion coating compositions containing a starch with high amylose content |
FR2934467B1 (en) * | 2008-07-31 | 2014-08-22 | Roquette Freres | FILMED SOLID FORM AND AMBIENT TEMPERATURE FILMING METHOD. |
KR101382650B1 (en) | 2011-10-25 | 2014-04-08 | 주식회사 케이티앤지 | Coating composition of low ignition propensity cigarette paper and cigarette using the same |
FR2997818B1 (en) * | 2012-11-14 | 2015-10-23 | Roquette Freres | GELIFIED CONFECTIONERY AND PROCESS FOR PREPARING SUCH CONFECTIONERY |
KR101365971B1 (en) * | 2013-01-11 | 2014-02-24 | 주식회사 파리크라상 | Brightener of bakery products and manufacturing methods thereof |
CN103638001A (en) * | 2013-12-10 | 2014-03-19 | 中国科学院长春应用化学研究所 | Vegetable hard capsules and preparation method thereof |
CN104804224B (en) * | 2015-05-13 | 2017-04-26 | 湖南尔康制药股份有限公司 | Starch film forming composition |
CN109562075A (en) * | 2016-07-05 | 2019-04-02 | 葛兰素史克消费保健(美国)控股有限责任公司 | Peroral dosage form comprising quick release outer coatings |
EP3360544A1 (en) * | 2017-02-08 | 2018-08-15 | Roquette Freres | Film-forming compositions for hard capsule shells and hard capsule shells obtained thereof |
US10582720B2 (en) * | 2017-03-17 | 2020-03-10 | Corn Products Development, Inc. | Baked snack coating using waxy corn starch |
CN110025004B (en) * | 2019-05-22 | 2022-02-11 | 广西壮族自治区农业科学院 | Potato dry rice noodles and preparation method thereof |
CN112137984B (en) * | 2020-10-30 | 2023-02-03 | 四川制药制剂有限公司 | Cefaclor capsule and preparation process thereof |
CN113117153B (en) * | 2021-05-22 | 2022-04-15 | 深圳市炫丽塑胶科技有限公司 | Hydrophilic lubricating coating for medical catheter surface |
KR102626286B1 (en) * | 2023-04-18 | 2024-01-18 | 종근당건강 주식회사 | Composition for vegetable soft capsule shell and vegetable soft capsule shell prepared from the same |
Family Cites Families (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1787777A (en) * | 1926-12-10 | 1931-01-06 | Parke Davis & Co | Capsule machine |
US3185626A (en) * | 1963-03-06 | 1965-05-25 | Sterling Drug Inc | Tablet coating method |
US3652294A (en) * | 1970-08-19 | 1972-03-28 | Nat Starch Chem Corp | Manufacture of starch-containing food products |
US3751277A (en) * | 1971-03-24 | 1973-08-07 | Dow Chemical Co | Tablet coating process and composition |
US3802896A (en) * | 1972-05-15 | 1974-04-09 | Nutrilite Products | Color concentrated base dispersion used in tablet film coating |
US4001211A (en) * | 1974-12-02 | 1977-01-04 | The Dow Chemical Company | Pharmaceutical capsules from improved thermogelling methyl cellulose ethers |
US4267164A (en) * | 1980-01-31 | 1981-05-12 | Block Drug Company Inc. | Effervescent stannous fluoride tablet |
US4313765A (en) * | 1980-09-24 | 1982-02-02 | Merck & Co., Inc. | Synergistic blends of cellulase-free xanthan gum and cellulosics |
DK151608C (en) * | 1982-08-13 | 1988-06-20 | Benzon As Alfred | PROCEDURE FOR PREPARING A PHARMACEUTICAL PERORAL POLYDEPOT PREPARATION WITH CONTROLLED RELEASE |
JPS59193831A (en) * | 1983-04-18 | 1984-11-02 | Sankyo Co Ltd | Preparation of enteric drug |
US4505890A (en) * | 1983-06-30 | 1985-03-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation and method |
US4576646A (en) * | 1983-07-06 | 1986-03-18 | Seppic | Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions |
US4828841A (en) * | 1984-07-24 | 1989-05-09 | Colorcon, Inc. | Maltodextrin coating |
US4643894A (en) * | 1984-07-24 | 1987-02-17 | Colorcon, Inc. | Maltodextrin coating |
JPS61100519A (en) * | 1984-10-23 | 1986-05-19 | Shin Etsu Chem Co Ltd | Hard capsule for drug |
US4652313A (en) * | 1984-10-24 | 1987-03-24 | Crompton And Knowles Corporation | Aqueous lake pigment suspension |
GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
US4892742A (en) * | 1985-11-18 | 1990-01-09 | Hoffmann-La Roche Inc. | Controlled release compositions with zero order release |
US5023108A (en) * | 1986-01-13 | 1991-06-11 | Research Corporation | Aqueous dispersions of waxes and lipids for pharmaceutical coating |
GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
US4904476A (en) * | 1986-03-04 | 1990-02-27 | American Home Products Corporation | Formulations providing three distinct releases |
US4802924A (en) * | 1986-06-19 | 1989-02-07 | Colorcon, Inc. | Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products |
US4820529A (en) * | 1986-06-26 | 1989-04-11 | Asahi Denka Kogyo Kabushiki Kaisha | Process for preparing pasty proteinous material or proteinous food from crustaceans |
US4800083A (en) * | 1986-10-20 | 1989-01-24 | R. P. Scherer Corporation | Sustained release method and product |
US4981698A (en) * | 1986-12-23 | 1991-01-01 | Warner-Lambert Co. | Multiple encapsulated sweetener delivery system and method of preparation |
US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
US4816259A (en) * | 1987-02-12 | 1989-03-28 | Chase Chemical Company, L.P. | Process for coating gelatin capsules |
US4820524A (en) * | 1987-02-20 | 1989-04-11 | Mcneilab, Inc. | Gelatin coated caplets and process for making same |
US4913893A (en) * | 1987-08-28 | 1990-04-03 | Clairol Incorporated | Aerosol hair setting composition containing an alginate |
US5009897A (en) * | 1988-06-24 | 1991-04-23 | Abbott Laboratories | Pharmaceutical granules and tablets made therefrom |
US4999189A (en) * | 1988-11-14 | 1991-03-12 | Schering Corporation | Sustained release oral suspensions |
US5186930A (en) * | 1988-11-14 | 1993-02-16 | Schering Corporation | Sustained release oral suspensions |
NZ233403A (en) * | 1989-04-28 | 1992-09-25 | Mcneil Ppc Inc | Simulated capsule-like medicament |
US5082669A (en) * | 1989-07-20 | 1992-01-21 | Dainippon Pharmaceutical Co., Ltd. | Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked |
US5209933A (en) * | 1990-01-10 | 1993-05-11 | Syntex (U.S.A.) Inc. | Long acting calcium channel blocker composition |
US5198227A (en) * | 1990-01-22 | 1993-03-30 | Mcneil-Ppc, Inc. | Dual subcoated simulated capsule medicament |
FR2660317B1 (en) * | 1990-03-27 | 1994-01-14 | Seppic | FILM-FORMING PRODUCT FOR COATING SOLID FORMS; ITS MANUFACTURING PROCESS AND PRODUCTS COATED WITH THIS PRODUCT. |
IT1246383B (en) * | 1990-04-17 | 1994-11-18 | Eurand Int | METHOD FOR MASKING THE TASTE OF DRUGS |
US5213738A (en) * | 1990-05-15 | 1993-05-25 | L. Perrigo Company | Method for making a capsule-shaped tablet |
US5422121A (en) * | 1990-11-14 | 1995-06-06 | Rohm Gmbh | Oral dosage unit form |
US5098715A (en) * | 1990-12-20 | 1992-03-24 | Burroughs Wellcome Co. | Flavored film-coated tablet |
US5591455A (en) * | 1990-12-20 | 1997-01-07 | Warner-Jenkinson Company, Inc. | Wet powder film-forming compositions |
EP0569408B1 (en) * | 1990-12-20 | 2000-05-03 | Warner-Jenkinson Company, Inc. | Wet powder film-forming compositions |
GB9104890D0 (en) * | 1991-03-08 | 1991-04-24 | Glaxo Group Ltd | Compositions |
ATE183642T1 (en) * | 1991-10-04 | 1999-09-15 | Yoshitomi Pharmaceutical | DELAYED-RELEASE TABLET |
ES2106818T3 (en) * | 1991-10-30 | 1997-11-16 | Glaxo Group Ltd | MULTILAYER COMPOSITION CONTAINING HISTAMINE OR SECOTIN ANTAGONISTS. |
AU661080B2 (en) * | 1991-11-22 | 1995-07-13 | Warner Chilcott Company, Llc | Risedronate delayed-release compositions |
WO1993014158A1 (en) * | 1992-01-17 | 1993-07-22 | Berwind Pharmaceutical Services, Inc. | Film coatings and film coating compositions based on cellulosic polymers and lactose |
US5286502A (en) * | 1992-04-21 | 1994-02-15 | Wm. Wrigley Jr. Company | Use of edible film to prolong chewing gum shelf life |
SE501389C2 (en) * | 1992-04-24 | 1995-01-30 | Leiras Oy | Pharmaceutical preparation and process for its preparation |
PH30929A (en) * | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
IT1255522B (en) * | 1992-09-24 | 1995-11-09 | Ubaldo Conte | COMPRESSED FOR THERAPEUTIC USE SUITABLE FOR SELLING ONE OR MORE ACTIVE SUBSTANCES WITH DIFFERENT SPEEDS |
US5411746A (en) * | 1993-02-24 | 1995-05-02 | Warner-Jenkinson Company, Inc. | Dye compositions and methods for film coating tablets and the like |
US5914132A (en) * | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
US5382435A (en) * | 1993-03-24 | 1995-01-17 | Southwest Research Institute | Microparticulate pharmaceutical delivery system |
SE9301057L (en) * | 1993-03-30 | 1994-10-01 | Pharmacia Ab | Controlled release preparation |
US5635208A (en) * | 1993-07-20 | 1997-06-03 | Mcneil-Ppc, Inc. | Granulation process for producing an acetaminophen and diphenhydramine hydrochloride composition and composition produced by same |
AU4701593A (en) * | 1993-07-22 | 1995-02-20 | Esseti S.A.S. Laboratorio Chimico Farmaco Biologico Di A. Ievoli & C. | Oral pharmaceutical compositions comprising reduced glutathion |
US5506248A (en) * | 1993-08-02 | 1996-04-09 | Bristol-Myers Squibb Company | Pharmaceutical compositions having good dissolution properties |
JP2916978B2 (en) * | 1993-08-25 | 1999-07-05 | エスエス製薬株式会社 | Controlled release initiation type formulation |
AU680019B2 (en) * | 1993-08-30 | 1997-07-17 | Warner-Lambert Company Llc | Tablet coating based on a melt-spun mixture of a saccharide and apolymer |
US5773025A (en) * | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
EP0736041B1 (en) * | 1993-11-17 | 2006-02-08 | Athena Neurosciences, Inc. | Transparent liquid for encapsulated drug delivery |
US6210714B1 (en) * | 1993-11-23 | 2001-04-03 | Euro-Celtique S.A. | Immediate release tablet cores of acetaminophen having sustained-release coating |
US5482718A (en) * | 1994-03-23 | 1996-01-09 | Hoffmann-La Roche Inc. | Colon-targeted delivery system |
JP2917799B2 (en) * | 1994-03-11 | 1999-07-12 | 田辺製薬株式会社 | Gastrointestinal tract release formulation |
GB9408117D0 (en) * | 1994-04-23 | 1994-06-15 | Smithkline Beecham Corp | Pharmaceutical formulations |
GB2288813A (en) * | 1994-04-28 | 1995-11-01 | Procter & Gamble | Granular Detergent Composition |
US6077533A (en) * | 1994-05-25 | 2000-06-20 | Purdue Pharma L.P. | Powder-layered oral dosage forms |
GB9414045D0 (en) * | 1994-07-12 | 1994-08-31 | Berwind Pharma Service | Moisture barrier film coating composition, method, and coated form |
JP3355593B2 (en) * | 1994-08-19 | 2002-12-09 | 信越化学工業株式会社 | Method for producing solid enteric preparation |
US5733575A (en) * | 1994-10-07 | 1998-03-31 | Bpsi Holdings, Inc. | Enteric film coating compositions, method of coating therewith, and coated forms |
US5498709A (en) * | 1994-10-17 | 1996-03-12 | Mcneil-Ppc, Inc. | Production of sucralose without intermediate isolation of crystalline sucralose-6-ester |
US5756123A (en) * | 1994-12-01 | 1998-05-26 | Japan Elanco Co., Ltd. | Capsule shell |
US6245350B1 (en) * | 1994-12-16 | 2001-06-12 | Warner-Lambert Company | Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process |
CA2205553C (en) * | 1994-12-16 | 2009-04-07 | Warner-Lambert Company | Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process |
EP0717992A3 (en) * | 1994-12-21 | 1998-03-25 | McNEIL-PPC, INC. | Aqueous suspension formulations for pharmaceutical applications |
US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
WO1997004752A1 (en) * | 1995-07-26 | 1997-02-13 | Duramed Pharmaceuticals, Inc. | Pharmaceutical compositions of conjugated estrogens and methods for their use |
US5712310A (en) * | 1996-06-14 | 1998-01-27 | Alpharma Uspd, Inc. | Suspension of substantially water-insoluble drugs and methods of their manufacture |
KR20000029784A (en) * | 1996-08-02 | 2000-05-25 | 나까도미 히로다카 | Capsules for oral preparations and capsule preparations for oral administration |
US6238704B1 (en) * | 1996-09-13 | 2001-05-29 | Shionogi & Co., Ltd. | Sustained-release preparation utilizing thermal change and process for the production thereof |
EP0930874A2 (en) * | 1996-10-09 | 1999-07-28 | Takeda Chemical Industries, Ltd. | A method for producing a microparticle |
CN1515247A (en) * | 1997-01-06 | 2004-07-28 | ���µ�˹ҩ����Ʒ��˾ | Paint film based on dextrin and its composite |
US6183808B1 (en) * | 1997-01-06 | 2001-02-06 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on dextrin |
US5891474A (en) * | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
EP1004310B1 (en) * | 1997-06-20 | 2009-06-17 | Ohkura Pharmaceutical Co., Ltd. | Gelled composition |
NZ503086A (en) * | 1997-08-29 | 2002-03-01 | Upjohn Co | An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes |
US6066336A (en) * | 1997-09-29 | 2000-05-23 | Bristol-Myers Squibb Company | Cholesterol-lowering tablets |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6214376B1 (en) * | 1998-08-25 | 2001-04-10 | Banner Pharmacaps, Inc. | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
FR2783832A1 (en) * | 1998-09-30 | 2000-03-31 | Warner Lambert Co | Compositions for manufacture of pharmaceutical capsules comprise hydroxy propylated starch and hydrocolloid plus cation hardening system |
US6485747B1 (en) * | 1998-10-30 | 2002-11-26 | Monsanto Company | Coated active tablet(s) |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6340473B1 (en) * | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
US6228400B1 (en) * | 1999-09-28 | 2001-05-08 | Carlsbad Technology, Inc. | Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
US6375981B1 (en) * | 2000-06-01 | 2002-04-23 | A. E. Staley Manufacturing Co. | Modified starch as a replacement for gelatin in soft gel films and capsules |
US6579545B2 (en) * | 2000-12-22 | 2003-06-17 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an antigas agent |
-
2002
- 2002-05-13 AU AU40617/02A patent/AU4061702A/en not_active Abandoned
- 2002-05-14 CA CA2386278A patent/CA2386278C/en not_active Expired - Fee Related
- 2002-05-14 NZ NZ518951A patent/NZ518951A/en unknown
- 2002-05-14 AR ARP020101763A patent/AR035899A1/en unknown
- 2002-05-14 KR KR1020020026391A patent/KR20020087367A/en not_active Application Discontinuation
- 2002-05-14 JP JP2002139176A patent/JP2003089659A/en active Pending
- 2002-05-14 EP EP02253341A patent/EP1260218B1/en not_active Expired - Lifetime
- 2002-05-14 AT AT02253341T patent/ATE516798T1/en not_active IP Right Cessation
- 2002-05-14 MX MXPA02004824A patent/MXPA02004824A/en active IP Right Grant
- 2002-05-15 BR BR0201905-1A patent/BR0201905A/en not_active Application Discontinuation
- 2002-05-15 CO CO02041350A patent/CO5390071A1/en not_active Application Discontinuation
- 2002-05-15 CN CN02121868A patent/CN1388190A/en active Pending
-
2008
- 2008-12-15 US US12/335,069 patent/US20090092739A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20020087367A (en) | 2002-11-22 |
CO5390071A1 (en) | 2004-04-30 |
NZ518951A (en) | 2003-09-26 |
US20090092739A1 (en) | 2009-04-09 |
EP1260218B1 (en) | 2011-07-20 |
AU4061702A (en) | 2003-04-03 |
CN1388190A (en) | 2003-01-01 |
JP2003089659A (en) | 2003-03-28 |
ATE516798T1 (en) | 2011-08-15 |
EP1260218A2 (en) | 2002-11-27 |
MXPA02004824A (en) | 2007-09-07 |
CA2386278C (en) | 2010-08-24 |
BR0201905A (en) | 2003-04-22 |
AR035899A1 (en) | 2004-07-21 |
EP1260218A3 (en) | 2003-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2386278A1 (en) | Dip coating compositions containing starch or dextrin | |
CA2386339A1 (en) | Dip coating compositions containing cellulose ethers | |
ES2390584T3 (en) | Film-forming starchy composition | |
US5178868A (en) | Dosage form | |
US6348090B1 (en) | Film coatings and film coating compositions based on dextrin | |
US6183808B1 (en) | Film coatings and film coating compositions based on dextrin | |
US4802924A (en) | Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products | |
CA2405530A1 (en) | Film forming compositions containing sucralose | |
CA2461275C (en) | Compositions containing sucralose | |
RU2006140093A (en) | SHELLS CONTAINING SUGAR AND WAYS OF USE THEREOF | |
CA2436386A1 (en) | Polyacrylic film forming compositions | |
HUT64220A (en) | Process for producing chewable tablet containing ibuprophene with taste inhibitor | |
US6468561B1 (en) | Aqueous film coating with improved properties | |
WO1998030341A9 (en) | Film coatings and film coating compositions based on dextrin | |
HUT64833A (en) | Soft capsule with coating dissoluble in intestines and method for manufacturing it | |
GB2057876A (en) | Enteric coated solid pharmaceutical unit dosage forms | |
KR20020087380A (en) | Simethicone as weight gain enhancer | |
US5741507A (en) | Ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating | |
WO1997009967A1 (en) | Flavour-masking film-forming composition | |
US20030203098A1 (en) | Coating system | |
KR101074496B1 (en) | Enteric coated composition and preparation method thereof | |
Deasy et al. | Correlation of surface characteristics with ease of production and in vitro release of sodium salicylate from various enteric coated microcapsules prepared by pan coating | |
JPS59139266A (en) | Production of enteric coatng preparation | |
US20060051420A1 (en) | Pharmaceutical tablets containing tibolone and a coating | |
IE58262B1 (en) | Substained release tablets and method for preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20180514 |